Target intelligence / Profile preview

tRNA (adenine(37)-N6)-methyltransferase (TRMO)

Target
TRMO
Molecular classification
Enzyme, Methyltransferase, tRNA-modifying enzyme
01

Overview

tRNA (adenine(37)-N6)-methyltransferase (TRMO) is an enzyme responsible for the methylation of adenine at the N6 position at the 37th nucleotide of certain tRNAs, a modification critical for the maintenance of correct codon–anticodon pairing and translational fidelity during protein synthesis. Like other tRNA methyltransferases, TRMO is a member of the class I methyltransferase family, characterized by the Rossmann-like fold. Its activity ensures proper tRNA structure and function, preventing translational errors. Aberrant function or misregulation of tRNA-modifying enzymes, including TRMO, has been linked to human diseases such as cancer and metabolic impairment through the disruption of normal translational fidelity and protein homeostasis[1][2][4]. TRMO shares sequence and structural features with other methyltransferases and is essential for normal cellular biosynthetic processes.

Other names
tRNA methyltransferase OC9orf156HSPC219NAP1Nef (lentivirus myristoylated factor) associated protein 1nef-associated protein 1thioesterase NAP1
02

Mechanism of action

Catalyzes N6-methylation of adenine(37) in tRNA, facilitating proper decoding and translation; may regulate the stability and function of tRNA

03

Biological functions

tRNA modificationRegulation of translation fidelityMethylation of tRNA adenine(37) at N6 position
04

Disease associations

CancerMetabolic disturbancesPotential neurological roles (general for tRNA methyltransferases)
05

Safety considerations

Loss or misregulation may impair cellular translation fidelity and contribute to disease, including aggressive cancers and metabolic dysfunctions

Beyond the preview

Go deeper on tRNA (adenine(37)-N6)-methyltransferase (TRMO).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tRNA (adenine(37)-N6)-methyltransferase (TRMO).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call